ErikaHamiltonMD

Oncology • Nashville, TN

Physician

Join to view full profile

Dr. Hamilton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hamilton's full profile

Already have an account?

Office
250 25th Ave N
Suite 100
Nashville, TN 37203
Phone+1 919-668-1748

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2013
University of North Carolina HospitalsResidency, Internal Medicine, 2007 - 2009
University of North Carolina at Chapel Hill School of MedicineClass of 2007

Certifications & Licensure

TN State Medical License 2013 - 2025
NC State Medical License 2007 - 2014
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

1 citations
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Brea...
Aditya Bardia, Komal Jhaveri, Seock-Ah Im, Sonia Pernas, Michelino De Laurentiis
Journal of Clinical Oncology. 2025-01-20
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.
Nehal J Lakhani, Daphne Stewart, Debra L Richardson, Lauren E Dockery, Linda Van Le
Journal for Immunotherapy of Cancer. 2025-01-11
Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03.
Afshin Dowlati, Anne C Chiang, Andrés Cervantes, Sunil Babu, Erika Hamilton
Journal of Thoracic Oncology. 2025-01-02

Press Mentions

Pathway Optimization in Early Breast Cancer: Biomarkers, Therapies, and Shared Decision-MakingFebruary 7th, 2025